Table of Content




1. Executive Summary


2. Global In-Silico Drug Discovery Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global In-Silico Drug Discovery Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global In-Silico Drug Discovery Market by Type
3.3.1: Software as a service
3.3.2: Consultancy as a service
3.3.3: Software

3.4: Global In-Silico Drug Discovery Market by Target Therapeutic Area
3.4.1: Human Immunodeficiency Virus (HIV)
3.4.2: Infectious diseases
3.4.3: Metabolic disorders
3.4.4: Mental disorders
3.4.5: Musculoskeletal disorders
3.4.6: Neurological disorders
3.4.7: Oncological disorders
3.4.8: Respiratory disorders
3.4.9: Others

3.5: Global In-Silico Drug Discovery Market by Workflow
3.5.1: Discovery
3.5.2: Target identification
3.5.3: Reverse docking
3.5.4: Bioinformatics
3.5.5: Protein structure prediction
3.5.6: Target validation
3.5.7: Lead discovery
3.5.8: Pharmacophore
3.5.9: Others

3.6: Global In-Silico Drug Discovery Market by End Use
3.6.1: Contract research organizations
3.6.2: Pharmaceutical industry
3.6.3: Academic & research institutes
3.6.4: Others


4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global In-Silico Drug Discovery Market by Region
4.2: North American In-Silico Drug Discovery Market
4.2.2: North American In-Silico Drug Discovery Market by End Use: Contract research organizations, Pharmaceutical industry, Academic & research institutes, and Others


4.3: European In-Silico Drug Discovery Market
4.3.1: European In-Silico Drug Discovery Market by Type: Software as a service, Consultancy as a service, and Software
4.3.2: European In-Silico Drug Discovery Market by End Use: Contract research organizations, Pharmaceutical industry, Academic & research institutes, and Others


4.4: APAC In-Silico Drug Discovery Market
4.4.1: APAC In-Silico Drug Discovery Market by Type: Software as a service, Consultancy as a service, and Software
4.4.2: APAC In-Silico Drug Discovery Market by End Use: Contract research organizations, Pharmaceutical industry, Academic & research institutes, and Others


4.5: ROW In-Silico Drug Discovery Market
4.5.1: ROW In-Silico Drug Discovery Market by Type: Software as a service, Consultancy as a service, and Software
4.5.2: ROW In-Silico Drug Discovery Market by End Use: Contract research organizations, Pharmaceutical industry, Academic & research institutes, and Others



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global In-Silico Drug Discovery Market by Type
6.1.2: Growth Opportunities for the Global In-Silico Drug Discovery Market by Target Therapeutic Area
6.1.3: Growth Opportunities for the Global In-Silico Drug Discovery Market by Workflow
6.1.4: Growth Opportunities for the Global In-Silico Drug Discovery Market by End Use
6.1.5: Growth Opportunities for the Global In-Silico Drug Discovery Market by Region

6.2: Emerging Trends in the Global In-Silico Drug Discovery Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global In-Silico Drug Discovery Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global In-Silico Drug Discovery Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Curia
7.2: Certara
7.3: Charles River Laboratories
7.4: Chemical Computing
7.5: GenScript
7.6: Sygnature Discovery
7.7: Abzena